JPRN-UMIN000028000招募中2 期
A phase 2 study of transcatheter aterial chemoembolization using cisplatin and DC beads for advanced hepatocellular carcinoma - DEB-TACE(CDDP+DC beads)
ational Hospital Organization KURE Medical Center0 个研究点目标入组 30 人开始时间: 2017年8月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)HCC without stain on angiogram. (2)History of hypersensitivity to cisplatinum-containing drug. (3)distant metastasis (4)main portal tumor thrombosis or hepatic vein tumor thrombosis (5)Patients with intrahepatic AP shunt or AV shunt. (6)Patients with complications to be treated preferentially. (7)Patients who can not keep their rest during the procedure. (8)Patients who are concluded to be inappropriate to participate in this study by their physicians.
研究者
相似试验
已完成
1 期
Phase I/II study of transcatheter arterial chemo-embolization with DDP-H and degradable starch microspheres for hepatic metastases of colorectal cancerColorectal CancerJPRN-UMIN000001168Radiology, Nara Medical University Hospital27
已完成
2 期
PhaseII study of trancatheter arterial chemoembolizaion with miriplatin for hepatocellular carcinoma -Compared with retrospective historical cohort study with epirubicin hydrochlorideHepatocellular carcinomaJPRN-UMIN000005229ara Medical University, Department of Radiology33
已完成
不适用
A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401)nresectable hypervascular hepatocellular carcinomaJPRN-C000000049Japan Interventional Radiology in Oncology Study Group (JIVROSG)60
已完成
2 期
Phase II study: Transcatheter Arterial Chemoembolization Therapy In Combination with Sorafenib (TACTICS)HCCJPRN-UMIN000004316Japan Liver Oncology Group228
进行中（未招募）
不适用
Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC) - TACE and sorafenib for HCChistologically proven advanced hepatocellular carcinoma (HCC) not suitable for resection or liver transplantation but without extrahepatic manifestations and without previous treatment for HCCMedDRA version: 9.1Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableEUCTR2007-000730-40-DEHeinrich-Heine-Universität Düsseldorf